Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant Staphylococcus aureus.
Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant Staphylococcus aureus.
复制标题
DOI:
10.1021/acsinfecdis.1c00265
复制
发表时间:
2021-08-13
影响因子:
5.3
通讯作者:
Freundlich JS
中科院分区:
文献类型:
--
作者:
Patel JS;Norambuena J;Al-Tameemi H;Ahn YM;Perryman AL;Wang X;Daher SS;Occi J;Russo R;Park S;Zimmerman M;Ho HP;Perlin DS;Dartois V;Ekins S;Kumar P;Connell N;Boyd JM;Freundlich JS
We present the application of Bayesian modeling to identify chemical tools and/or drug discovery entities pertinent to drug-resistant Staphylococcus aureus infections. The quinoline JSF-3151 was predicted by modeling and then empirically demonstrated to be active against in vitro cultured clinical methicillin- and vancomycin-resistant strains while also exhibiting efficacy in a mouse peritonitis model of methicillin-resistant S. aureus infection. We highlight the utility of an intrabacterial drug metabolism (IBDM) approach to probe the mechanism by which JSF-3151 is transformed within the bacteria. We also identify and then validate two mechanisms of resistance in S. aureus: one mechanism involves increased expression of a lipocalin protein and the other arises from the loss of function of an azoreductase. The computational and experimental approaches, discovery of an antibacterial agent, and elucidated resistance mechanisms collectively hold promise to advance our understanding of therapeutic regimens for drug-resistant S. aureus.
登录
查看更多内容
影响因子:
3.7
作者:
El-Halfawy OM;Valvano MA
通讯作者:
Valvano MA
影响因子:
3.7
作者:
Ekins, Sean;Freundlich, Joel S.
通讯作者:
Freundlich, Joel S.
影响因子:
4.9
作者:
Inoyama, Daigo;Paget, Steven D.;Freundlich, Joel S.
通讯作者:
Freundlich, Joel S.
影响因子:
158.5
作者:
BARRETT, FF;MCGEHEE, RF;FINLAND, M
通讯作者:
FINLAND, M
影响因子:
6.4
作者:
Fey PD;Endres JL;Yajjala VK;Widhelm TJ;Boissy RJ;Bose JL;Bayles KW
通讯作者:
Bayles KW